| ACE-I | Angiotensin-converting enzyme inhibitors |
| AKI | Acute kidney injury |
| AKIN | Acute Kidney Injury Network |
| ARB | Angiotensin II receptor blockers |
| ASA | American Society of Anesthesiologists |
| BMI | Body mass index |
| BSA | Body surface area |
| CC score | Completeness of cytoreduction score |
| CRS | Cytoreductive surgery |
| CTCAE | Common Terminology Criteria for Adverse Events |
| DHP-I | Dehydropeptidase I |
| HIPEC | Hyperthermic intraperitoneal chemotherapy |
| HITOC | Hyperthermic intrathoracic chemotherapy |
| I/C | Imipenem/cilastatin |
| ICU | Intensive care unit |
| PCI | Peritoneal cancer index |
| RIFLE | Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease |